SMBD - Jewish General Hospital
3755 Cote Ste Catherine
Dept of Microbiol
Montreal
QCCanada
H3T 1E2
Biographical Sketch: Dr. Mark Miller studied at McGill University in Infectious Diseases and in Medical Microbiology and then pursued a Master’s degree in Epidemiology and Biostatistics. He has been a staff microbiologist and infectious disease specialist at the Jewish General Hospital, a McGill University-affiliated hospital, since 1993 where he is the Chair of Infection Prevention and Control, the Chief of Clinical Microbiology, and the Head of Infectious Diseases. He is an Assistant Professor of Medicine and Microbiology/Immunology at McGill University.
His research focuses on the epidemiology, prevention, and treatment of healthcare-associated infections. He has described the rapid emergence of mupirocin resistance among MRSA, chaired the cross-Canada group studying the morbidity, health effects, and mortality from healthcare-associated C. difficile infection (CDI), and headed the Canadian team which surveyed the reuse of single-use medical devices. He is currently studying CDI in depth, including the recent epidemiology of severe CDI in Canada, CDI prevention using Lactobacillus probiotics, and CDI therapy with novel antibiotics and immunomodulators.
He also helped establish the Quebec province-wide guidelines for physicians, dentists, and other healthcare workers infected with blood-borne diseases and is the Chairman of the Infection Control Working Group of McGill University, which harmonizes infection control policies in all McGill-affiliated health institutions. He has co-authored over 90 publications and presented over 100 abstracts. He is past-president of the Association of Medical Microbiology and Infectious Disease of Canada (AMMI-Canada), the professional society of Canadian physicians involved in the prevention, treatment, and research in the field of Infectious Diseases. He currently lives in Montreal, Canada.